✦ LIBER ✦

Topical diphencyprone immunotherapy for cutaneous metastatic melanoma

✍ Scribed by Diona L Damian; Kerwin F Shannon; Robyn P Saw; John F Thompson

Book ID: 108928892
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 880 KB
Volume: 50
Category: Article
ISSN: 0004-8380
DOI: 10.1111/j.1440-0960.2009.00556.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy for metastatic melanoma

✍ Christopher R. Zito; Harriet M. Kluger 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin‐2, has resulted in prolonged responses in a small subset of

Systemic treatments for metastatic cutan

Systemic treatments for metastatic cutaneous melanoma

📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

IMMUNOTHERAPY, INCLUDING GENE THERAPY, F

IMMUNOTHERAPY, INCLUDING GENE THERAPY, FOR METASTATIC MELANOMA

✍ Michael G. E. O'Rourke; Christopher W. Schmidt; Thomas R. O‘rourke; Kay A. O. El 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 951 KB

Cutaneous melanoma: available therapy fo

Cutaneous melanoma: available therapy for metastatic disease

✍ Ahmad A. Tarhini; Sanjiv S. Agarwala 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Topical toremifene: a new approach for c

Topical toremifene: a new approach for cutaneous melanoma?

✍ Juhani Maenpaa; Thomas Dooley; Gregory Wurz; John VandeBerg; Edward Robinson; Ve 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 407 KB

Immune-mediated red cell aplasia after a

Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma

✍ Ilyssa O. Gordon; Takisha Wade; Kevin Chin; Jerome Dickstein; Thomas F. Gajewski 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 298 KB